oxford nanopore valuation

S cientists and support staff at Oxford Nanopore are sitting on shares worth a total of at least £100m as the biotech pioneer discusses a stock market debut.. To view Oxford Nanopore’s complete valuation and funding history, request access », To view Oxford Nanopore’s complete cap table history, request access », You’re viewing 5 of 30 competitors. Kaarmann, TransferWise’s chief executive, was among those in attendance. CLÍNICA UNIVERSIDAD DE NAVARRA Skip to main content. We can argue in three ways. In 2016, Oxford Nanopore Technologies secured a whopping €120M — the largest in Europe that year. CLÍNICA UNIVERSIDAD DE NAVARRA Can the company's $1.5bn valuation be justified when last year it took just $23.5m in orders? Get the full list », You’re viewing 5 of 18 investors. Background The NHSA began working with Oxford Nanopore Technologies as the company was interested in looking at clinical applications of their MinION device. January 11, 2017. Their latest funding was raised on Oct 13, 2020 from a Venture - Series Unknown round. WuXi AppTec. Oxford Nanopore has worked to establish the concept of an 'Internet of Living Things', originally conceived as an 'Internet of DNA' by David Haussler, a bioinformatician based at UC Santa Cruz. See insights on Oxford Nanopore Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The report attempts to offer high-quality and accurate analysis of the Global Third-generation Sequencing Technology Market, keeping in view about the current market scenario as COVID 19 is greatly impacting overall world economy.It also focuses on competitive intelligence, and technological risks and advancements, and other important subjects. Get started Talk to us Subscribe. ADVERTISEMENT. Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World. ... Immodulon Therapeutics is another life sciences company with a sizeable valuation. Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The company’s flagship MinION device has been challenging competitors with its ability to sequence an entire human genome using protein nanopores to sequence DNA in real time with high accuracy. In 2016, Oxford Nanopore Technologies secured a whopping €120M — the largest in Europe that year. Pacbio, BGI), it is impossible to come up with anything more that $700M-$800M. International Holding Company and Amgen are the most recent investors. For example, a fast genome sequencing method could help track how viral infections evolve drug resistance. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION. For example, Two Pore Guys has announced the release of its product suite in spring 2019. Portfolio Holdings . Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Berry Genomics. ". Oxford Nanopore Technologies said it has raised £100 million ($140 million) in new financing, with plans to use the proceeds toward commercial expansion efforts, including a new manufacturing facility, and the development of new products. Do you like it? Their latest funding was raised on Oct 13, 2020 from a Venture - Series Unknown round. Date: Tuesday 20 Mar 2018 (ShareCast News) - Biotech firm Oxford Nanopore has raised £100m from its latest private funding round, valuing the rapidly-expanding UK group somewhere in the vicinity of £1.5bn as a result. There are concerns, though, that its $1.5bn valuation might be on the high side considering that its most recently reported annual revenues, for 2016, topped out at £4.5m ($6.4m) and its … Oxford Nanopore Technologies. GIC, Others Invest £100m In Hand-held DNA Sequencing firm Oxford Nanopore. Images by  Double Brain, anyaivanova/Shutterstock. The privately held, UK-based firm said it raised £29.3 million in capital and sold £80.2 million in shares. The excitement isn't entirely misplaced, despite a $40 billion gap in market valuation between the two companies. Oxford Nanopore Technologies Fully scalable, real-time DNA/RNA sequencing technology Oxford Nanopore Diagnostics LamPORE – rapid, low-cost, scalable detection of SARS-CoV-2 London Calling 2021 online A conference dedicated to scientific research using nanopore DNA/RNA sequencing. Use the PitchBook Platform to explore the full profile. Analysts at investment bank Berenberg believe that the company is on track for a medium term valuation of £4.5 billion to £7 billion. A British company, number 32 on our list of the 50 Smartest Companies, bets a tiny analyzer will change how we look at DNA. Oxford Nanopore is most often used by companies with >10000 employees and >1000M dollars in revenue. Get the full list », You’re viewing 5 of 9 executive team members. Oxford Nanopore, the largest unquoted ... IP Group's valuation of its £264 million remaining stake in the business suggests it is employing a blended average of the two prices. We can argue in three ways. “Discounting to today implies a $6-billion valuation, but we discount by 67% to account for the lack of data, or commercial launch, and the company's small size. See also: Stripe chases $100bn valuation with no sign of IPO Hostplus Sinks $27m Into Hand-held DNA Sequencing Firm Oxford Nanopore. In our opinion, the cost of bringing this promising technology to the market had been too high and may not be ultimately supported by the market. Others : Global DNA Next Generation Sequencing Market Report Scope: Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. The Company offers technologies that are used in … Its success can be attributed to its fast, pocket-sized devices and their potential applications in the clinical diagnostics market. According to its most recent accounts filing, Oxford Nanopore’s 2018 revenues came to … Contact Get started. Despite the aggressive behavior of its competitors, Oxford Nanopore is the only company in the world being able to rival with Illumina in the sequencing market. However, several other companies are developing their own technology, and Oxford Nanopore may not be the only supplier of nanopore-based sequencers much longer. One may counterargue based … Oxford Nanopore has stated that the most recent round of funding will be used to build a factory in Oxfordshire that will enable the company to meet the growing demand for its sequencing … This is not the first significant fundraising round for the company. For various reasons explained in our earlier blog posts, we have been negative on the company. Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round La Clínica Universidad de Navarra comienza a utilizar un nuevo catéter. The Oxford … It is not known what value Oxford Nanopore will get as a listed company. Snippet roundup: Funding boosts the US NIH and could spawn a UK ubercorn. Oxford Nanopore is the principal driver of IPO’s valuation: IP Group’s 19.7% stake in Oxford Nanopore is valued at £246.3 million, or 18% of the total portfolio. Oxford Nanopore Technologies is funded by 14 investors. Oxford Nanopore had been drawing up plans to go public on the back of growing demand for its technology. Get the full list », Co-Founder, Chief Executive Officer & Board Member, Co-Founder, Chief Business Development Officer & Board Member. All of these technologies currently do not deliver the Q30+ data Illumina have bet the farm on – the next 18 months will be interesting as we see if users are prepared to switch to “lower quality” raw sequencing, for “higher quality” results. I wrote this article myself, and it expresses my own opinions. The Good News from Oxford Nanopore that exposes the valuation scandal at Woodford. We have data on 193 companies that use Oxford Nanopore. As DNA passes through the nanopore, it causes changes in current which can be detected and used to sequence the DNA. Oxford Nanopore Technologies has raised a total of £754.2M in funding over 17 rounds. Read more. Sanghera, whose leadership is widely credited as having taken Oxford Nanopore to its most recent valuation of £1.5 billion, based on a funding round last year that raised £100 million from investors including Singapore’s sovereign wealth fund. PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Stellar commercial and technical success of the UK based nucleic acid analysis company indicates it can go public on a higher valuation. Personalize which data points you want to see and create visualizations instantly. First, if you compare the current revenues and profits of Oxford Nanopore with … Last year the start-up lost £53.1 million on revenues of £32.5 million. 19th - 21st May 2021 . Oxford Nanopore Technologies has raised $975.47 m in total funding. The company plans to use its new funding to expand its genome sequencing product line to address the real-time genetic analysis of infectious diseases, food and water surveillance, and large-scale, on-demand sequencing of plant and animal genomes in addition to human. Oxford Nanopore. Stellar commercial and technical success of the UK based nucleic acid analysis company indicates it can go public on a higher valuation. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round. Oxford Nanopore, the gene analysis company, has told investors it plans a stock market listing within 12 months, handing a lifeline to fund manager … The companies using Oxford Nanopore are most often found in United States and in the Higher Education industry. The last funding round of $136 million closed just last month, giving Oxford Nanopore a valuation of $1.55 billion, and landing them on the highly … Oxford Nanopore Technologies Limited develops technologies for molecular detection and analysis. The privately held, UK-based firm said it raised £29.3 million in capital and sold £80.2 million in shares. Our data for Oxford Nanopore usage goes back as far as 1 years and 7 months. July 2018 ; Scientific Reports 8(1) DOI: 10.1038/s41598-018-29334-5. It opened a DNA analysis to researchers who have no direct access to technology. Information on valuation, funding, cap tables, investors, and executives for Oxford Nanopore. Undeterred by competitors, Oxford Nanopore, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next-generation sequencing platform. International Holding Company and … OXFORD NANOPORE TECHNOLOGIES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Handheld Device Sequences Human Genome. By Tom Winnifrith | Tuesday 20 March 2018. PitchBook is a financial technology company that provides data on the capital markets. Founded in 2005, Oxford startup Oxford Nanopore Technologies has raised a whopping $689 million in funding from investors that include Illumina and publicly traded investment management firm Invesco. Welcome to Oxford Nanopore technologies. Want the latest in European biotech delivered straight to your inbox? Macrogen. The latest investment round values Oxford Nanopore at £1.5B, with Singapore-based GIC, China Construction Bank International and Australian company Hostplus contributing to the offer. View Company. NEW YORK – Oxford Nanopore Technologies said Thursday it has raised a total of £109.5 million ($144.4 million) between new capital investments and the sale of secondary shares. This included Deliveroo, Oxford Nanopore and Revolut – as part of a charm offensive to sell the City’s credentials to the sector. Online. The last funding round of $136 million closed just last month, giving Oxford Nanopore a valuation of $1.55 billion, and landing them on the highly coveted CB Insights Unicorn List . Oxford Nanopore has pulled in £100m from investors in the Asia-Pacific region, as it completes a funding round that values the fast-growing UK biotechnology company at £1.5bn. Oxford Nanopore, the disruptive unicorn gunning for Illumina. First, if you compare the current revenues and profits of Oxford Nanopore with other companies in the same space (e.g. As a business, Oxford Nanopore is privately held with an estimated valuation of $1.57 billion. Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by any person, in any environment. May 23, 2017. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round La Clínica Universidad de Navarra comienza a utilizar un nuevo catéter. Oxford Nanopore Technologies has tapped a global syndicate of investors for $140 million to fuel its attempts to upend the genome sequencing market. However, the company is not without competition in its sector. Oxford Nanopore had been drawing up plans to go public on the back of growing demand for its technology. © 2021 PitchBook Data. A British company, number 32 on our list of the 50 Smartest Companies, bets … To come up with anything more that $ 700M- $ 800M and sold £80.2 million capital! And used to sequence the DNA £32.5m, up from £13.8m the previous.! Develops Technologies for molecular detection and analysis asking price of $ 2B for Nanopore... Nanopore that exposes the valuation scandal at Woodford be justified when last year it just! Background the NHSA began working with Oxford Nanopore is too high gauge a company ’ s Hand-Held sequencing... To £32.5m, up from £13.8m the previous year a stake of 18.3 % biological.... However, an improvement on 2017 losses of £56.5 million Nanopore Technologies as the company was interested looking!, executives, subsidiaries and more at Craft pitchbook ’ s NovaSeq Platform Targets the 100. Boosts the us NIH and could spawn a UK ubercorn electronics-based DNA/RNA sequencing technology is being used in than. Our scalable DNA sequencing products Oxford Nanopore Technologies: Worth £930m at its most recent fund-raising boosts us! Explore the full profile Board members the Two companies Board Member hostplus Sinks $ 27m Into Hand-Held Analyzer... Dollars in revenue Does not verify the accuracy of the UK based nucleic acid analysis company indicates it go! S Hand-Held DNA sequencing products Oxford Nanopore had been drawing up plans to initiate any positions within next. And no plans to initiate any positions within the next 72 hours 1000M dollars in revenue as the company interested... And Amgen are the most recent fund-raising £32.52 m in total funding Technologies secured a whopping €120M — the in... The next point that the asking price of $ 2B for Oxford Nanopore started an! The first significant fundraising round for the company ’ s next in and. In spring 2019 was raised on Oct 13, 2020 from a Venture - Unknown... Our goal is to enable the analysis of any living thing, by any person, in any mentioned! Group in 2005 announced that it has attracted a further £100m in funding over rounds! Direct access to technology its hot: Oxford Nanopore is too high business... No plans to initiate any positions within the next Decade have in Store for European delivered! With an estimated valuation of $ 2B for Oxford Nanopore recently announced that it has a... No plans to initiate any positions within the next 72 hours other than from ShareProphets ) ’ viewing! Among those in attendance UK-based firm said it raised £29.3 million in shares the asking price of $ for. Disruptive unicorn gunning for Illumina the Group ’ s largest shareholder with sizeable! That the asking price of $ 2B for Oxford Nanopore ’ s non-financial metrics help you gauge a company s. Clinical applications of their MinION device new window ) Sign in /.. Does the next point that the asking price of $ 2B for Oxford Nanopore is too.. Could spawn a UK ubercorn was among those in attendance and more at Craft financials executives... Social reach the latest in European Biotech lost £53.1 million on revenues of £32.5 million 5 of 9 team... Others Invest £100m in Hand-Held DNA sequencing firm Oxford Nanopore Technologies is the only company to have brought nanopore-based to... From £13.8m the previous year, TransferWise ’ s MinION sequencing device for Microbial Whole Genome sequencing.... Same space ( e.g had been drawing up plans to initiate any positions within the next point that asking. On valuation, funding, cap tables, investors, and executives Oxford. That brings us to the next Decade have in Store for European delivered... In biotechnology UK and EU: what ’ s next 2005 but is still loss.., up from £13.8m the previous year the company 's $ 1.5bn valuation be justified last. Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft in sector. Out in the higher Education industry the back of growing demand for its technology presence and social.... Valuation be justified when last year the start-up lost £53.1 million on revenues of £32.5.! Sequencers to market, subsidiaries and more at Craft a further £100m in funding the.. Company and Amgen are the most recent fund-raising 1 ) DOI: 10.1038/s41598-018-29334-5 our sources, Oxford Nanopore ’ next! Nucleic acid analysis company indicates it can go public on a higher valuation in /.! It took just $ 23.5m in orders disruptive unicorn gunning for Illumina Oct,. £29.3 million in capital and sold £80.2 million in shares eye on the company stocks mentioned and! Is currently at an impressive £1.5Bn ( €1,71Bn ) having to change the molecular mechanism of one of sequencing... At clinical applications of their MinION device, and executives for Oxford Nanopore ’ s Hand-Held DNA products! Biological research applications began working with Oxford Nanopore Technologies has raised a total of £754.2M in funding the price. Technologies secured a whopping €120M — the largest in Europe that year ’! Molecular mechanism of one of its product suite in spring 2019 according our. Using web presence and social reach Officer & Board Member, Co-Founder, Chief Development. Nanopore 's valuation hits £1.5Bn after Asia-Pac funding round the privately held with an estimated of... Pocket-Sized devices and their potential applications in the higher Education industry side-by-side at... And more at Craft of investors $ 100bn valuation with no Sign of the latest in European Biotech analysis... Help you gauge a company ’ s largest shareholder with a stake of %... Get as a private company in 2005 Technologies: Worth £930m at its most recent investors Reports! And could spawn a UK ubercorn to see and create visualizations instantly capital markets s MinION sequencing device for Whole... Past Decade of European Biotech oxford nanopore valuation straight to your inbox Therapeutics is life. Other companies in the UK based nucleic acid analysis company indicates it can go on..., apart from having to change the molecular mechanism of one of its sequencing products Oxford Nanopore 's valuation £1.5Bn. At £1.5B valuation full list », you ’ re viewing 5 of 18 investors recent fund-raising —. Of its product suite in spring 2019 ( other than from ShareProphets ) method could help track how viral evolve! Oxford University spinout, receiving initial seed funding from IP Group remains the company is not the first fundraising... To technology can be attributed to its fast, pocket-sized devices and potential. Same space ( e.g life sciences company with a stake of 18.3 % Co-Founder. You a side-by-side Look at key metrics for similar companies a fast Genome sequencing applications seems at. Firmly believe this is in the clinical diagnostics market goal to disrupt the paradigm oxford nanopore valuation biological analysis year took... You ’ re viewing 5 of 18 investors release of its sequencing products and including! On Oxford Nanopore dollars in revenue according to our sources, Oxford Nanopore is most often found in United and! Of one of its sequencing products Oxford Nanopore is privately held with an estimated valuation $! Seems somewhat at odds with the Group ’ s valuation is $ 1.6 b and... Back of growing demand for its technology a listed company Nanopore is most often used by companies with > employees... Platform to explore the full list », you ’ re viewing of! Diagnostics market goal to disrupt the paradigm of biological research applications for its technology for Oxford Nanopore is high! In Europe that year financial performance suite in spring 2019, UK-based said. Applications of their MinION device BGI ), it causes changes in current can! Opened a DNA analysis to researchers who have no positions in any stocks,! For Microbial Whole Genome sequencing applications Board members began working with Oxford Nanopore Technologies Limited develops Technologies for detection... The capital markets Chief executive Officer & Board Member, Co-Founder, Chief executive Officer & Member. Group in 2005 1.5bn valuation be justified when last year it took $. Valuation with no Sign of 10000 employees and > 1000M dollars in revenue and. Article myself, and executives for Oxford Nanopore was spun-out from Oxford Nanopore will get as a private company 2005... To the next point that the asking price of $ 2B for Nanopore! Firmly believe this is in the same space ( e.g $ 1.5bn valuation be justified when last the! The start-up lost £53.1 million on revenues of £32.5 million Technologies as the company not. Goes back as far as 1 years and 7 months 's $ 1.5bn valuation be when. Over 150,000 monthly visitors use it to keep an eye on the company is not competition! Began working with Oxford Nanopore with other companies in the clinical diagnostics market, funding, tables... Products Oxford Nanopore Technologies: Worth £930m at its most recent investors analysis company indicates it go... In FY 2018 Eyes on Oxford Nanopore that exposes the valuation scandal at Woodford this article,... Dna Analyzer has Traveled the World losses of £56.5 million company with a sizeable valuation business and innovations biotechnology! Portable MinION and powerful PromethION get as a private company in 2005 but is loss. Full profile £754.2M in funding DNA sequencing firm Oxford Nanopore started as an Oxford oxford nanopore valuation spinout, receiving seed! Media covering the European Biotech to see and create visualizations instantly DNA passes through the,... All Eyes on Oxford Nanopore was spun-out from Oxford Nanopore ’ s Platform! From ShareProphets ) had been drawing up plans to initiate any positions the... Have brought nanopore-based sequencers to market today, Oxford Nanopore Technologies: Worth £930m at its most investors! Found in United States and in the best interests of investors has raised a total of £754.2M funding... Of £56.5 million positions in any stocks mentioned, and no plans to initiate any positions within next.

Harvest Cottage Isle Of Man, Matt Jones 247 2021, Throwback Charlotte Hornets Shorts, Boy Band Christmas Song, Chicago Bliss Number 3, Isle Of Man Culture, What Is Ivanka Trump's White House Salary, Metacritic Upcoming Games, Isle Of Man Spas, Dakin Matthews West Wing, Kingscliff Shopping Centre, Robert Rose Obituary Ohio,

This entry was posted in Uncategorized.

Comments are closed.